Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Statistics

Total Valuation

LGND has a market cap or net worth of $2.00 billion. The enterprise value is $1.77 billion.

Market Cap	2.00B
Enterprise Value	1.77B

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

LGND has 19.28 million shares outstanding. The number of shares has increased by 4.84% in one year.

Current Share Class	19.28M
Shares Outstanding	19.28M
Shares Change (YoY)	+4.84%
Shares Change (QoQ)	+1.14%
Owned by Insiders (%)	1.99%
Owned by Institutions (%)	97.42%
Float	18.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	34.02
PS Ratio	10.54
Forward PS	10.57
PB Ratio	2.47
P/TBV Ratio	4.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.22

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.76
EV / EBITDA	94.98
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.01.

Current Ratio	5.27
Quick Ratio	4.29
Debt / Equity	0.01
Debt / EBITDA	0.22
Debt / FCF	n/a
Interest Coverage	-5.47

Financial Efficiency

Return on equity (ROE) is -16.56% and return on invested capital (ROIC) is -1.29%.

Return on Equity (ROE)	-16.56%
Return on Assets (ROA)	-1.14%
Return on Invested Capital (ROIC)	-1.29%
Return on Capital Employed (ROCE)	-1.96%
Revenue Per Employee	$2.67M
Profits Per Employee	-$1.95M
Employee Count	68
Asset Turnover	0.20
Inventory Turnover	1.92

Taxes

Income Tax	-28.49M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is 0.76, so LGND's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+40.00%
50-Day Moving Average	107.70
200-Day Moving Average	109.51
Relative Strength Index (RSI)	42.09
Average Volume (20 Days)	102,820

Short Selling Information

The latest short interest is 1.14 million, so 5.93% of the outstanding shares have been sold short.

Short Interest	1.14M
Short Previous Month	1.01M
Short % of Shares Out	5.93%
Short % of Float	6.06%
Short Ratio (days to cover)	8.71

Income Statement

In the last 12 months, LGND had revenue of $181.49 million and -$132.62 million in losses. Loss per share was -$7.11.

Revenue	181.49M
Gross Profit	147.02M
Operating Income	-16.63M
Pretax Income	53.01M
Net Income	-132.62M
EBITDA	18.66M
EBIT	-16.63M
Loss Per Share	-$7.11

Balance Sheet

The company has $208.90 million in cash and $4.45 million in debt, giving a net cash position of $204.45 million or $10.60 per share.

Cash & Cash Equivalents	208.90M
Total Debt	4.45M
Net Cash	204.45M
Net Cash Per Share	$10.60
Equity (Book Value)	795.53M
Book Value Per Share	41.45
Working Capital	250.63M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 81.01%, with operating and profit margins of -9.16% and -73.07%.

Gross Margin	81.01%
Operating Margin	-9.16%
Pretax Margin	-88.77%
Profit Margin	-73.07%
EBITDA Margin	10.28%
EBIT Margin	-9.16%
FCF Margin	n/a

Dividends & Yields

LGND does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.84%
Shareholder Yield	-4.84%
Earnings Yield	-6.71%
FCF Yield	n/a

Analyst Forecast

The average price target for LGND is $144.67, which is 39.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$144.67
Price Target Difference	39.28%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	16.17%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 19, 2010. It was a reverse split with a ratio of 0.16666:1.

Last Split Date	Nov 19, 2010
Split Type	Reverse
Split Ratio	0.16666:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2